The recent move of the European Medicines Agency from London to Amsterdam is a reflection of the city’s vibrant life sciences and health sector and supporting industries.

Scientifically groundless regulations could undercut the potential of gene-edited crops, much as they have with GMOs.

Mauro Ferrari says the organization’s response to the COVID-19 pandemic is inadequate, but ERC members claim his proposals didn’t align with the mission of the council.

The plan to revitalize the European innovation landscape is entering a transition.

Higher ed professionals from EU and non-EU countries are departing for jobs elsewhere, perhaps reflecting uncertainty over funding availability.

Prime Minister Boris Johnson says the immigration program will help the nation remain a science superpower post-Brexit.

Public health care will take a hit however Britain leaves the European Union, but a no-deal exit will cause the most harm, a new analysis shows.

Nearly three dozen Nobel laureates and Fields Medal winners sign a letter to the UK Prime Minister and the President of the European Commission.

As Britain’s departure date from the European Union approaches, drugmakers are preparing for potential changes to regulatory procedures and border controls.